We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+0.35%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$1.63B
AUM Growth
+$1.24M
Cap. Flow
+$8.83M
Cap. Flow %
0.54%
Top 10 Hldgs %
35.93%
Holding
239
New
7
Increased
89
Reduced
89
Closed
17

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$3.46M
2
OTLY
Oatly Group
OTLY
+$2.87M
3
TILE icon
Interface
TILE
+$2.55M
4
TMUS icon
T-Mobile US
TMUS
+$2.51M
5
BXP icon
Boston Properties
BXP
+$1.26M

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$4.44M
2
XLNX
Xilinx Inc
XLNX
+$2.73M
3
ORA icon
Ormat Technologies
ORA
+$1.52M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$979K
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$863K

Sector Composition

Rank Sector Weight
1 Healthcare 25.57%
2 Technology 20.23%
3 Industrials 13.9%
4 Communication Services 11.84%
5 Consumer Discretionary 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UL icon
26
Unilever
UL
$133B
$24.5M 1.5%
402,235
-3,076
-0.8% -$196K
BDX icon
27
Becton Dickinson
BDX
$48.9B
$22.5M 1.38%
93,663
+3,624
+4% +$889K
NVO
28
Novo Nordisk
NVO
$202B
$22.2M 1.36%
461,910
+21,268
+5% +$1.03M
WM icon
29
Waste Management
WM
$90.8B
$20.8M 1.27%
139,068
+3,314
+2% +$496K
CVS icon
30
CVS Health
CVS
$120B
$20.8M 1.27%
244,528
+11,283
+5% +$945K
JNJ icon
31
Johnson & Johnson
JNJ
$627B
$19M 1.16%
117,690
-1,424
-1% -$243K
PG icon
32
Procter & Gamble
PG
$335B
$17.1M 1.05%
122,210
+545
+0.4% +$77.3K
SBUX icon
33
Starbucks
SBUX
$122B
$16.1M 0.98%
145,589
+8,021
+6% +$939K
SYY icon
34
Sysco
SYY
$40.1B
$15.1M 0.92%
192,332
-4,991
-3% -$381K
MKTX icon
35
MarketAxess Holdings
MKTX
$5.72B
$14.7M 0.9%
35,041
+407
+1% +$187K
APH icon
36
Amphenol
APH
$211B
$14.6M 0.89%
399,150
+12,080
+3% +$444K
VEEV icon
37
Veeva Systems
VEEV
$38.1B
$14.6M 0.89%
50,581
-80
-0.2% -$25.4K
HD icon
38
Home Depot
HD
$343B
$13.4M 0.82%
40,943
+430
+1% +$141K
XLNX
39
DELISTED
Xilinx Inc
XLNX
$12.7M 0.78%
83,885
-18,640
-18% -$2.73M
BXP icon
40
Boston Properties
BXP
$10.7B
$12.5M 0.77%
115,753
+11,055
+11% +$1.26M
TDOC icon
41
Teladoc Health
TDOC
$1.2B
$12.4M 0.76%
97,550
-30,482
-24% -$4.44M
TJX icon
42
TJX Companies
TJX
$170B
$11.2M 0.69%
170,216
+9,729
+6% +$679K
NVS icon
43
Novartis
NVS
$290B
$10.6M 0.65%
129,351
-630
-0.5% -$56.7K
TILE icon
44
Interface
TILE
$2.19B
$8.96M 0.55%
591,191
+177,376
+43% +$2.55M
TMO icon
45
Thermo Fisher Scientific
TMO
$222B
$7.26M 0.44%
12,716
+189
+2% +$104K
BEAM icon
46
Beam Therapeutics
BEAM
$2.79B
$6.33M 0.39%
72,798
+1,693
+2% +$170K
FISV
47
Fiserv Inc
FISV
$27B
$6.29M 0.39%
57,952
-6,641
-10% -$742K
ABBV icon
48
AbbVie
ABBV
$442B
$5.21M 0.32%
48,280
+306
+0.6% +$35K
V icon
49
Visa
V
$670B
$5M 0.31%
22,441
+748
+3% +$175K
COST icon
50
Costco
COST
$420B
$4.87M 0.3%
10,839
+323
+3% +$142K
1
2
3 4 5

Similar funds

SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
C
Consulta London, United Kingdom $2.01B AUM 16.82% 1-Year Est. Return

Reynders McVeigh Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Reynders McVeigh Capital Management held 239 positions worth $1.63B, up 0.08% from $1.63B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Reynders McVeigh Capital Management's Q3 2021 filing shows 7 new, 89 increased, 89 reduced and 17 closed positions. Its largest new stake was Revvity: 5,324 shares worth $923K. The largest sale was Teladoc Health, an estimated $4.44M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

  • Reynders McVeigh Capital Management's largest Q3 2021 buy was Revvity: 5,324 shares worth $923K.
  • Reynders McVeigh Capital Management added most to Medtronic in Q3 2021, an estimated $3.46M increase.
  • Reynders McVeigh Capital Management's biggest Q3 2021 reduction was Teladoc Health, cutting an estimated $4.44M.
  • Reynders McVeigh Capital Management fully exited Brookfield Renewable in Q3 2021, selling an estimated $518K.
  • Reynders McVeigh Capital Management's ten largest holdings make up 36% of its $1.63B portfolio in Q3 2021.
  • Reynders McVeigh Capital Management opened 7 new positions and closed 17 in Q3 2021.
  • Reynders McVeigh Capital Management's portfolio value rose 0.08% quarter-over-quarter to $1.63B.

Based on Reynders McVeigh Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.